Advisory Team

Senior Advisor

Senior Advisor

Dr. Annalisa Jenkins

+X BIO

Dr. Annalisa Jenkins is a life sciences thought leader with over 20 years of biopharmaceutical industry experience. Prior to joining PlaqueTec as CEO in November 2017, Dr. Jenkins served as president and CEO of Dimension Therapeutics, a leading gene therapy company that was acquired by Ultragenyx in November 2017. Prior leadership roles have included the head of global research and development and executive vice president global development and medical at Merck Serono, and several senior positions at Bristol Myers-Squibb over 15 years - including serving as senior vice president and head of global medical affairs. Earlier in her career, Dr. Jenkins was a medical officer in the British Royal Navy during the Gulf Conflict, achieving the rank of surgeon lieutenant commander. Dr. Jenkins is a board member of several growing companies, including Ardelyx, Inc., iOX Therapeutics Limited, Thrombolytic Strategies Incorporated, PhESi, Oncimmune, Cocoon Biotech Inc. (Non Executive Chair), Cellmedica (Non-Executive Chair), Vium, Inc. (Executive Chair), and Silence Therapeutics (Non-Executive Chair). She also is a committee member of the Science Board to the U.S. Food & Drug Administration (FDA), and serves on the board of the Center for Talent Innovation in the U.K. Dr. Jenkins graduated with a degree in medicine from St. Bartholomew’s Hospital in the University of London and subsequently trained in cardiovascular medicine in the U.K. National Health Service.

Scientific & Medical Advisory Team

Scientific & Medical Advisory Team

Professor Sir George Alberti

+X BIO

Current posts:
Visiting Professor Kings College, London
Senior Research Investigator, Imperial College, London
Emeritus Professor of Medicine, University of Newcastle.
Previous posts:
Chair, Kings College Hospital NHS Foundation Trust 2011-2015; Senior Advisor, London SHA; National Director for Emergency Access & Service Configuration, Department of Health 2002-2009; President, Royal College of Physicians 1997-2002; Dean of Medicine University of Newcastle 1995-1997; Professor of Medicine University of Newcastle 1985-2002; President International Diabetes Federation 200-2003; President European Association for the Study of Diabetes 1992-1995; Chair Great North Air Ambulance Service 2006-2012

Scientific & Medical Advisory Team

Sir David Barnes

+X BIO

Bio to follow.

Scientific & Medical Advisory Team

Bob Damms

+X BIO

Bob Damms MA (Cantab) is an expert in the assessment and development of new products and technologies. He has over 25 years' experience of developing new biomedical technologies through roles in industry, consulting, venture capital and equities research. He has worked across most biomedical subsectors, including biotechnology, pharmaceuticals, medical devices and eHealth, and from university start-ups, SMEs, global corporations and governments. His particular interests include the convergence of technologies in the healthcare sector, translational research, and novel commercialisation models. He is currently seconded to the UKTI's Venture Capital unit.

Scientific & Medical Advisory Team

Dr. Carl Brookes

+X BIO

Carl Brookes DM FRCP trained at Oxford University and St Thomas' Hospital, London.  He has been a Consultant Physician and Cardiologist at Hampshire Hospitals Foundation Trust since 2000. He runs a comprehensive invasive and non-invasive cardiology service and is also the Divisional Medical Director for Medical Services overseeing 1500 staff with a budget of £80m. He has widespread research interests across cardiology and internal medicine including diabetes mellitus.

Business & Financial Advisory Team

Business & Financial Advisory Team

Charlotte Barford

+X BIO

Charlotte Barford is the Managing Director of Clive Barford Ltd (CBL) and has a proven track record of leadership roles in large, multinational organisations, having previously worked in the fast moving consumer goods sector and at various international locations. Charlotte started her career at Bain and Company management consulting, after studying Mathematics at Oxford University. Following a year working for a charity in Poland, Charlotte was awarded an MBA from Harvard and worked for United Biscuits Plc in London and Chicago in various strategy and management roles, before joining CBL. Charlotte lives in London with her husband and two daughters and is a trustee of LEYF (London Early Years Foundation).

Business & Financial Advisory Team

Philip Daubeney

+X BIO

Philip Daubeney MA (Oxon) was for many years the CEO of ICI Africa and Asia (forerunner of AstraZeneca) that included responsibility for their pharmaceutical interests. During this period he undertook a large number of corporate mergers, acquisitions and company disposals. He then became CEO at the Electricity Association and Non-Executive Chairman of the JP Morgan Indian Investment Trust. He is currently Non-Executive Chairman of the International Air Compressors Association and Chairman of AFNOR UK, a subsidiary of AFNOR France, the French Standards Body. He brings significant expertise in corporate governance, compliance and a proven track record in the development and then sale of individual corporate entities.